Gitnux/Report 2026

Digital Pathology Industry Statistics

The global digital pathology market is estimated at $1.54 billion in 2026, explore the figures behind growth, companies, and adoption shifts toward enterprise platforms.
25Statistics
34Sources
6Sections
1Visuals
16mRead
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The digital pathology industry at a glance

The global digital pathology market is estimated at $1.54 billion in 2026, with adoption expanding as laboratories combine whole-slide imaging, workflow software, and AI-enabled analysis.

$1.54B[5]
2026 market size
11.5%[5]
2026–2035 CAGR
39.92%[4]
North America share, 2025
15%[15]
U.S. practices using primary diagnosis, 2025
Market size
The global digital pathology market was estimated at $1.37 billion in 2025 and $1.54 billion in 2026. Another 2026 estimate placed the 2025 market at $1.53 billion, illustrating the variation caused by differing market definitions and coverage.[5][4]
Forecast & CAGR
Global Market Insights forecasts the market to reach $4.1 billion by 2035 at an 11.5% CAGR from 2026 to 2035. Grand View Research projects $3.0 billion by 2033 at an 8.6% CAGR from 2026 to 2033.[5][4]
Market share & regions
North America held the largest regional share in 2025, at 39.92% in Grand View Research's estimate and 36.74% in Fortune Business Insights' estimate. Asia-Pacific is identified as the fastest-growing region in both outlooks.[4][6]
Segmentation
Software was the largest product segment in 2025, accounting for 42.88% of market revenue in Grand View Research's segmentation. Oncology represented 52.02%, academic research 45.76%, and hospitals 37.15% in their respective application, therapeutic-area, and end-use segments.[4]
Key players & concentration
Global Market Insights estimated Danaher as the leading company with more than 15.4% of 2025 market share. Its five leading companies—Danaher, Roche, Fujifilm, Hamamatsu Photonics, and Olympus—collectively accounted for 46.2%.[5]
Pricing
The Digital Pathology Association reports that whole-slide scanners typically cost between $50,000 and $300,000, depending on slide capacity and features. Total implementation costs also include storage, data management, software, and operating personnel.[16]
Trends, drivers & challenges
Growth is being driven by AI-assisted image analysis, oncology workflows, remote consultation, precision medicine, and demand for faster and more collaborative diagnostics. Adoption remains constrained by scanner and storage costs, high-performance computing requirements, laboratory-information-system integration, validation, and workforce training.[5][15][17]
Consumer behavior & competition
The main buyers are hospitals, diagnostic laboratories, academic medical centers, pharmaceutical companies, and research organizations. In the College of American Pathologists' 2025 survey, only 15% of practices reported using whole-slide imaging for primary diagnosis, while academic and reference laboratories were more likely to digitize slides for research, consultation, and tumor boards.[15]
M&A
M&A is combining pathology laboratories, scanners, image-management platforms, and AI capabilities. Quest Diagnostics acquired select PathAI Diagnostics assets in 2024 for $100 million, while Tempus announced its acquisition of Paige in 2025 to add AI-enabled digital pathology to its precision-medicine platform.[18][19]
Regulation
In the United States, whole-slide imaging systems are regulated medical devices, and the FDA recorded a substantially equivalent 510(k) decision for Roche Digital Pathology Dx on December 17, 2024. Clinical deployment also requires laboratory validation and compliance with applicable quality and diagnostic-use requirements.[20][16]
Latest news
Recent industry activity has centered on consolidation and AI integration: Tempus announced the acquisition of Paige in 2025, while 2026 market reporting continues to describe a shift from standalone scanner purchases toward enterprise imaging platforms that combine whole-slide imaging, software, AI, and laboratory integration.[19][5]

02 Ranking

Top 10 Companies in the Digital Pathology Industry

The leading companies in the digital pathology industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

Roche stands out for clinical whole-slide scanning and workflow software because it sells VENTANA DP scanners and digital pathology workflow software for clinical diagnosis, while Proscia focuses on digital pathology workflows and AI applications since its Concentriq platform manages digital pathology workflows and AI applications.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in digital pathology workflow

    Roche

    CH

    Ranked #1 · 9.3 · Digital pathology workflow

    Why we picked it: Its digital pathology offering combines scanners and workflow software, with a substantially equivalent 510(k) decision recorded in 2024.

  2. Leader in AI-enabled pathology analysis

    Proscia

    US

    Ranked #2 · 9.3 · AI-enabled pathology analysis

    Why we picked it: Concentriq is built around end-to-end digital pathology workflow management tied to AI applications.

  3. Leader in enterprise image management

    Sectra

    SE

    Ranked #3 · 9.0 · Enterprise image management

    Why we picked it: Its enterprise imaging platform is designed for pathology alongside other specialties in the same imaging environment.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the digital pathology industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Roche

Digital pathology workflow · CH

9.3
2

Proscia

AI-enabled pathology analysis · US

9.3
3

Sectra

Enterprise image management · SE

9.0
4

PathAI

AI-enabled pathology analysis · US

9.0
5

Indica Labs

AI-enabled pathology analysis · US

8.7
6

Hamamatsu Photonics

NanoZoomer whole-slide scanners · JP

8.5
7

Danaher

Leica Biosystems pathology workflow and imaging · US

8.5
8

Huron Technologies

Digital pathology scanners and workflow platform · CA

8.3
9

3DHISTECH

Whole-slide scanners and pathology software · HU

7.8
10

OptraSCAN

Scanners, AI analysis and image management · US

7.5

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 10 companies in the digital pathology industry. In Digital Pathology Industry Statistics. Gitnux. https://gitnux.org/digital-pathology-industry-statistics/#top-companies

report visual · Comparison

Digital pathology market revenue by region

Asia Pacific holds the largest share at $570.0M.

Asia Pacific$570.0M
North America$410.0M
Europe$270.0M
Latin America$60.0M
Middle East and Africa$40.0M
source-verifiedreportsinsights.com

04 Statistics

Technology & AI

AI adoption concentrates on image-analysis applications, with 87% of AI adopters using them. Regulatory eligibility also shows a measured pipeline: 26 AI products from 15 companies.

AI features and adoption in the digital pathology industry

  • 87% of AI adopters in the digital pathology survey were using image-analysis applications, compared with process automation as another reported AI use.[1]
  • 26 digital pathology AI products from 15 companies had regulatory approval for placement on the EEA or GB market under the study’s eligibility criteria.[2]
  • 82% of life-sciences organizations using digital pathology had implemented AI applications in the 2023 survey of 40 executives from major pharmaceutical companies and CROs.[1]

05 Statistics

Market Intelligence

Market sizing differs by definition, including $1.37 billion in 2025 in one estimate and $1.53 billion in another 2025 estimate. In 2026, the market is estimated at $1.54 billion.

Market size and revenue in the digital pathology industry

  • US$226 million was the estimated 2025 global digital pathology software and platform market, covering web-based and desktop software for hospitals, diagnostic centres, laboratories and research institutes.[3]
  • US$1.5 billion was the 2025 global digital pathology market size, covering hardware, software and storage systems; software represented 42.88% of revenue.[4]
  • US$1.37 billion was the 2025 global digital pathology market size, covering products, software, scanners, image-management systems and AI-based image analysis.[5]

Growth forecasts for the digital pathology industry

  • The global digital pathology market is projected to reach US$5.75 billion by 2034, at an 18.56% CAGR from 2026 to 2034; the scope includes hardware, software and storage systems.[6]
  • The global digital pathology market is projected to reach US$3.0 billion by 2033, growing at an 8.6% CAGR from 2026 to 2033; the scope includes hardware, software and storage systems.[4]
  • The global digital pathology market is projected to reach US$4.1 billion by 2035, growing at an 11.5% CAGR from 2026 to 2035; the scope includes scanners, software, platforms and related systems.[5]

Product counts and provider structure in the digital pathology industry

  • 115 products performed image analysis on H&E-stained histological tissue images in the reviewed digital pathology AI product population.[2]
  • 60 companies were identified as developing digital pathology AI-based image-analysis software in a review of publicly available products.[2]
  • 12 leading companies were profiled in a global digital pathology software and platform market study covering hospitals, diagnostic centres, laboratories and research institutes.[3]

06 Statistics

Customers & Revenue

Clinical primary diagnosis uptake stays limited: only 15% of U.S. practices reported using whole-slide imaging for primary diagnosis in 2025. Survey results for life sciences also show wide use: 70% in February 2023.

Buyer penetration in the digital pathology industry

  • Fewer than 15% of U.S. healthcare organizations were at any stage of digital-pathology deployment in 2026; the denominator was U.S. healthcare organizations.[7]
  • 70% of surveyed life-sciences organizations currently used digital pathology in February 2023; the denominator was 40 executives from pharmaceutical companies and CROs in the United States, Europe, Middle East and Africa.[1]
  • Fewer than 10% of U.S. organizations had adopted digital pathology for clinical use in 2023; the denominator was U.S. healthcare organizations.[8]

07 Statistics

Pricing & Packaging

Subscription pricing shows low-cost entry points alongside enterprise scale requirements, with SlideScope Plus at $50 per month observed in November 2026 and other tiers sold by case volume.

Price levels in the digital pathology industry

  • $50 per month was SlideScope Plus’s published subscription price, observed in November 2026; the product was sold globally in U.S. dollars.[9]
  • ฿39,900 per month was the published PATHOLOGY+ Lab + AI plan price for up to 30 users and 2,000 new cases monthly, observed in November 2026; the service was hosted and sold in Thailand.[10]
  • ฿14,900 per month was the published PATHOLOGY+ Lab plan price for up to 10 users and 500 new cases monthly, observed in November 2026; the service was hosted and sold in Thailand.[10]
  • $35 per month was SlideScope Individual’s published subscription price for opening users’ own digital-pathology images, observed in November 2026; the product was sold globally in U.S. dollars.[9]

08 Statistics

Security & Compliance

EU AI Act timing is specified for digital pathology AI within high-risk rules, with an application date of 2 August 2026 for most rules and 2 August 2028 for embedded high-risk systems.

Regulatory obligations in the digital pathology industry

  • 2 December 2027 is the application date for high-risk AI systems under Annex III of the EU AI Act in the EU, covering applicable stand-alone clinical AI software, including relevant digital-pathology applications.[11]
  • 2 August 2028 is the application date for high-risk AI systems embedded in regulated products under Annex I of the EU AI Act, including applicable AI-enabled medical-device software used in digital pathology.[12]
  • 2 August 2026 is the application date for most EU AI Act rules, including transparency requirements, for applicable AI software in the EU; digital-pathology AI systems are covered when they fall within the regulated-product framework.[11]

09 Statistics

Sustainability

Carbon accounting is quantified for digital pathology compute workloads, including 100.56 metric tonnes CO2-equivalent per year for seven deep-learning models in Aachen, Germany.

Energy use, emissions and disclosure in the digital pathology industry

  • 100.56 metric tonnes of CO2-equivalent emissions per year were modelled for seven deep-learning models applied to the same prostate and breast digital-pathology slide workload in Aachen, Germany.[13]
  • 1,103–2,923 tonnes of CO2-equivalent emissions were estimated for full digitalisation of surgical pathology in France, depending on external versus local storage and three-month versus one-year retention.[14]
  • 7.65 metric tonnes of CO2-equivalent emissions per year were modelled for one deep-learning model applied to all prostate and breast whole-slide images in digital pathology in Aachen, Germany, in the study scenario.[13]

Key questions about the digital pathology industry

What is the 2026 market size for digital pathology?
The global digital pathology market is estimated at $1.54 billion in 2026.
How fast is the digital pathology market growing over the next decade?
The 2026–2035 CAGR is 11.5%, with the market forecast to reach $4.1 billion by 2035.
Which companies lead the digital pathology industry?
Roche stands out for clinical whole-slide scanning and workflow software because it sells VENTANA DP scanners and digital pathology workflow software for clinical diagnosis, while Proscia focuses on digital pathology workflows and AI applications since its Concentriq platform manages digital pathology workflows and AI applications.
What technology shift is most visible in digital pathology adoption?
AI-enabled analysis tied to clinical workflows is expanding, with 87% of AI adopters using image-analysis applications and 82% of life-sciences organizations implementing AI applications in the 2023 survey.
How is the market structured across products and applications?
Software was the largest product segment in 2025 at 42.88% of market revenue in one estimate, while oncology is the leading use case at 52.02% in the corresponding end-use segment.
What constrains adoption and deployment in clinical settings?
Adoption remains constrained by scanner and storage costs, high-performance computing requirements, laboratory-information-system integration, validation, and workforce training.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). Digital Pathology Industry Statistics. Gitnux. https://gitnux.org/digital-pathology-industry-statistics
MLA
Samuel Norberg. "Digital Pathology Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/digital-pathology-industry-statistics.
Chicago
Samuel Norberg. 2026. "Digital Pathology Industry Statistics." Gitnux. https://gitnux.org/digital-pathology-industry-statistics.